Intercontinental Exchange enters August with a sharply changed analyst tone — the same firms that spent July cutting targets have started lifting them, a reversal that tells you everything about how the Q2 print landed.
The Street's pivot is the clearest story of the week. Three firms raised targets on July 31, the day after ICE reported Q2 results. UBS lifted to $195 from $190, maintaining Buy. TD Cowen moved more aggressively, raising to $177 from $159 while keeping its Buy rating. Barclays nudged to $182 from $180, holding Overweight. That follows a month of cuts from the same names — Goldman, Morgan Stanley, Barclays, and UBS had all trimmed through late June and early July. The consensus mean target now sits at $182, against a post-earnings close of $152.48. The gap is real, but it narrowed considerably: the stock has gained 24% over the past month and is now within striking distance of targets that seemed generous just weeks ago. Bulls continue to point to derivatives volume strength, particularly in energy, and the long-term margin story from the Black Knight integration. Bears maintain that ICE's earnings remain sensitive to volume cycles, and the slight top-line miss in Exchange and Mortgage Technology segments from previous quarters hasn't fully resolved.
Positioning in the lending market offers essentially no signal here — the borrow conditions are about as relaxed as they get. Short interest has dropped sharply, falling 16% over the past week to just 1.6% of the free float. Shares available to borrow are abundant, with availability at the system ceiling. Borrowing costs have eased to 0.33%, their lowest level in at least a month, down 24% on the week. The short score has drifted down from 31.3 to 29.9 over the past two weeks, consistent with shorts covering into the rally. There is no squeeze pressure and no meaningful short-side conviction — the lending market is simply not where the story lives right now.
Options positioning is equally calm. The put/call ratio ticked up to 0.36 on Friday, but that reading is almost exactly in line with the 20-day average of 0.36, with a z-score near zero. The 52-week low on the PCR was set on July 27 at 0.28, suggesting options traders have been positioned quite bullishly through most of July. Friday's slight uptick likely reflects routine post-earnings repositioning rather than any fresh defensive posture.
Institutional ownership is stable and dominated by passive vehicles. BlackRock holds 9.4% and added roughly 500,000 shares through June. T. Rowe Price and Wellington Management both built positions meaningfully, each adding around 2 million shares in Q2. JP Morgan Asset Management added over 3.4 million shares. The insider picture is less constructive in direction — Lynn Martin, President of the NYSE subsidiary, sold approximately $2.2 million of stock on July 16 in multiple tranches, and the CFO sold $390,000 in late May. Net insider selling over 90 days totals around $4.3 million. The trades carry low significance scores and are likely routine plan sales, but the direction is worth noting given the stock's 24% monthly run.
The next scheduled event is August 6 — another earnings-related date in the system — though the Q2 results themselves were already delivered on July 30. The post-Q2 reaction was a modest -1.2% on the day, a restrained move given the scale of the preceding rally. With targets now being revised upward and the stock trading at roughly 18.5x earnings and 14.3x EV/EBITDA — multiples that have expanded by 0.2x and 3.5 PE points respectively over the past 30 days — the key variable to watch is whether the revenue execution story in Mortgage Technology gains further traction, or whether the valuation re-rating runs ahead of it.
See the live data behind this article on ORTEX.
Open ICE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
